Neurocrine Biosciences Competitors and Similar CompaniesClear all
Kalaris Therapeutics's competitors and similar companies include CSL Behring and UCB.
 Kalaris Therapeutics Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2013 | Founding Date 1904 | Founding Date 1928 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ Dublin, IE Milan, IT | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 695% decrease | Employees 7,5692% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) 103.1 m | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €7.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($43.4m) (FY, 2025) | Net income N/A | Net income €1.6b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 100 (Dec, 2020) | Countries 35 (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company